Skip to main content

COVID-19 Topic Center

Bipolar Disorders News

News
A sustained score of 11 or lower on the Functioning Assessment Short Test (FAST) appears useful and achievable for gauging functional recovery in patients with bipolar I disorder, according to a study published in Neuropsychiatric Disease and Treatment.  “There is growing agreement,” researchers…
News
Telemedicine interventions may improve medication adherence in patients with bipolar disorder, depression, and schizophrenia, according to a systematic review published in General Hospital Psychiatry.  “Telemedicine interventions for adherence have the advantage over face-to-face interventions of…
News
People with HIV who have bipolar disorders or untreated depressive disorders experience more days with unsuppressed HIV viral load compared with people with HIV who do not have mood disorders, according to a study published recently in the Journal of Acquired Immune Deficiency Syndromes.  The…
News
People with bipolar disorder appear to be at greater risk of developing Parkinson disease compared with the general population, according to results from a systematic review and meta-analysis published online in JAMA Neurology.   “The main clinical implication of this review should be to underline…
News
Recently, researchers determined why it is important to address opioid use disorders, alcohol use, and depression among a cohort of veterans seeking pain care. According to research findings published online in Psychological Medicine, addressing comorbid opioid use disorders and psychiatric…
News
Study findings published online in Circulation: Cardiovascular Quality and Outcomes suggest that veterans diagnosed with psychosis, bipolar disorder, depression, anxiety, and posttraumatic stress disorder are at an increased risk for cardiovascular disease. “Although previous studies have…
News
Alkermes plc is expanding its New Drug Application (NDA) for the investigational drug ALKS 3831—a combination of the antipsychotic olanzapine and the novel molecular entity samidorphan—to include the treatment of bipolar I disorder as well as schizophrenia, the drugmaker recently announced. The…
News
Lumateperone, an investigational drug from Intra-Cellular Therapies, Inc., posted varied results in two phase 3 clinical trials evaluating it as a monotherapy for major depressive episodes associated with bipolar disorder. Study 404 was conducted globally, including in the United States, and…
News
People with bipolar disorder who smoke tobacco, whether or not they have other substance use disorders, are at a higher risk of repeating a suicide attempt, according to a study published in the Journal of Affective Disorders. “Substance use disorders (SUD) (including tobacco-related) are strongly…
News
The antipsychotic cariprazine was effective in improving depressive symptoms in patients with bipolar depression and concurrent manic symptoms, according to a poster presented at the American Psychiatric Association’s annual meeting. The poster analyzed pooled data from 3 randomized, double-blind…
Back to Top